These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24431106)

  • 21. Differential effects of MDMA and methylphenidate on social cognition.
    Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
    J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
    Mas M; Farré M; de la Torre R; Roset PN; Ortuño J; Segura J; Camí J
    J Pharmacol Exp Ther; 1999 Jul; 290(1):136-45. PubMed ID: 10381769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.
    Palamar JJ
    J Psychoactive Drugs; 2018; 50(1):88-93. PubMed ID: 28937933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ecstasy--cool dope with long-lasting effects?].
    Liberg JP; Hovda KE; Nordby G; Jacobsen D
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4384-7. PubMed ID: 9889612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.
    Parrott AC
    Hum Psychopharmacol; 2013 Jul; 28(4):289-307. PubMed ID: 23881877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
    Patel MM; Belson MG; Longwater AB; Olson KR; Miller MA
    J Emerg Med; 2005 Nov; 29(4):451-4. PubMed ID: 16243206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.
    Parrott AC
    Drug Alcohol Depend; 2012 Feb; 121(1-2):1-9. PubMed ID: 21924843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA; Rosner MH
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.
    de la Torre R; Farré M; Roset PN; Pizarro N; Abanades S; Segura M; Segura J; Camí J
    Ther Drug Monit; 2004 Apr; 26(2):137-44. PubMed ID: 15228154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ecstasy: psychostimulant, hallucinogen and toxic substance].
    Burnat P; Le Brumant-Payen C; Huart B; Ceppa F; Pailler FM
    Presse Med; 1996 Sep; 25(26):1208-12. PubMed ID: 8949626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxytocin receptor gene variation predicts subjective responses to MDMA.
    Bershad AK; Weafer JJ; Kirkpatrick MG; Wardle MC; Miller MA; de Wit H
    Soc Neurosci; 2016 Dec; 11(6):592-9. PubMed ID: 26787430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
    Jaehne EJ; Majumder I; Salem A; Irvine RJ
    Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
    Parrott AC
    Neuropsychobiology; 2004; 50(4):329-35. PubMed ID: 15539865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["Ecstasy" (MDMA): pharmacology, toxicology, and treatment of acute intoxication].
    Liechti ME
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1361-6. PubMed ID: 12802747
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Hanson KL; Luciana M
    J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between 3,4-methylenedioxymethamphetamine and ethanol in humans and rodents.
    Mohamed WM; Hamida SB; de Vasconcelos AP; Cassel JC; Jones BC
    Neuropsychobiology; 2009; 60(3-4):188-94. PubMed ID: 19893335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.